Skip to main content
. 2021 Jan 10;18(2):511. doi: 10.3390/ijerph18020511

Figure 3.

Figure 3

Overview of obesity-associated metabolic inflammation and insulin resistance. NLRP3 inflammasome activation as a consequence of obesity-mediated immunological and metabolic dysregulation, including changes in adipose tissue-resident immune cells, impaired adipogenesis, decreased anti-inflammatory adipokines, hypoxia, fibrosis, etc., and helped by oxidative and ER stress, leads to a glucotoxicity, lipotoxicity, and systemic insulin resistance.